NCT06935344 Evaluation of Polygenic Risk Score for Epithelial OVarian cancEr Risk Prediction: the PROVE Study Status RECRUITING Phase N/A
NCT06930755 Study of NMS-03305293 in Adult Patients With Relapsed Ovarian Cancer Status RECRUITING Phase PHASE1
NCT06926075 Early Phase Study of KESONOTIDE™in Participants With Solid Tumours Status RECRUITING Phase PHASE1/PHASE2
NCT06925126 Exosome-based Recurrence Score for Post-Treatment Ovarian Cancer Status NOT_YET_RECRUITING Phase N/A
NCT06925113 A Study to Investigate the Prevalence of Human Epidermal Growth Factor Receptor 2 (HER2) Immunohistochemistry (IHC) 3+ and Characterize the Clinicopathologic Features of Gynecologic Cancers in Taiwan Status COMPLETED Phase N/A
NCT06917469 Use of New MolEcular MarkErs for a persoNalized Therapy in Ovarian Cancer-MEMENTO Status COMPLETED Phase N/A
NCT06915025 Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer Status RECRUITING Phase PHASE3
NCT06907771 Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer Status RECRUITING Phase N/A
NCT06906341 Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers Status RECRUITING Phase PHASE2
NCT06902467 Combined Intraperitoneal Chemotherapy Regimen After Optimal Interval Surgery in Advanced Ovarian Cancer: BICOV-1 (Bidirectional Chemotherapy in Ovarian Cancer) Status RECRUITING Phase NA
NCT06890858 A Clinical Study on Fasudil Hydrochloride for Treatment of Gene-Specific Ovarian Cancer Status RECRUITING Phase PHASE2
NCT06888921 A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT06887673 Lipid Mediators & Cancer: Montelukast, SPM, and Almonds Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT06885424 A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products Status ENROLLING_BY_INVITATION Phase N/A
NCT06884345 METR-NK Cells in Combination With Anti-angiogenic Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT06879353 Comparison of Single-Dose Tranexamic Acid Vs. Placebo in Ovarian Cancer Surgery Status COMPLETED Phase NA
NCT06873555 A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumors Status RECRUITING Phase PHASE1/PHASE2
NCT06871787 Near-Infrared Fluorescence Imaging With Indocyanine Green to Evaluate Bowel Anastomoses in Gynecologic Oncology Surgery Status NOT_YET_RECRUITING Phase PHASE4
NCT06855069 HS-20089 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer Status RECRUITING Phase PHASE3